Contact this trialFirst, we need to learn more about you.
Radioisotope Therapy
Lu-DOTA-TATE for Neuroendocrine Carcinoma
Recruiting2 awardsPhase 2
Edmonton, Alberta
This trial is a prospective, single arm, open label study of Lu-DOTA-TATE in patients with well-differentiated, somatostatin receptor positive neuroendocrine tumours.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.